Many women avoid menopause hormone therapy because of fears rooted in 2002 headlines. Long-term research shows risk depends on age, timing, and hormone type. In 2025, the FDA began removing broad boxed-warning language about cardiovascular disease, breast cancer, and dementia, though the endometrial cancer warning remains for systemic estrogen alone. “Bioidentical” isn’t a safety rating, and compounded hormones fit specific needs. Your clinician can help you weigh your personal risks.

You haven’t slept through the night in months. Hot flashes interrupt meetings, and intimacy has become painful.

Yet when a friend asks why you haven’t tried hormone therapy, the answer comes fast: “Isn’t it dangerous? Doesn’t it cause cancer?” Hormone therapy myths like these keep many women from even starting the conversation with their doctor.

Those fears didn’t come from nowhere. They trace back to a major study and the alarming headlines that followed it more than two decades ago. But science has moved on. Long-term follow-up has added important context, and the Menopause Society now says that for many healthy women with symptoms, the benefits generally outweigh the risks.

Regulators have moved, too. In late 2025, the FDA began changing the warnings on menopausal hormone therapy labels.

In this article, our pharmacists separate common myths from what the evidence actually shows, including an honest look at compounded hormones. Our goal is to help you walk into your next appointment better informed. You can also learn more about our women’s health and hormone compounding services.

Where Hormone Therapy Myths Started: The WHI Study

Most hormone therapy myths trace back to July 2002, when the Women’s Health Initiative (WHI) stopped its estrogen-plus-progestin trial early after finding higher risks of breast cancer and cardiovascular events. Later analyses showed participants averaged 63 years old, and that age and timing significantly change the risk-benefit picture.

What the 2002 trial found

The WHI estrogen-plus-progestin trial enrolled more than 16,600 women and was halted on July 9, 2002. Researchers saw more invasive breast cancer, heart disease, strokes, and blood clots in the lungs among women taking hormones. The news spread quickly, and prescriptions dropped sharply.

What got less attention was who was in the study. As HHS noted in its 2025 announcement, participants averaged 63, more than a decade past the typical start of menopause.

What long-term follow-up showed

Researchers continued to track WHI participants for about 18 years. An analysis of 27,347 women, reported by TCTMD, found hormone therapy did not raise overall death rates. Women who started in their 50s had a lower death rate than those on placebo.

That doesn’t erase the original findings. It does show why a single headline turned into one of the most lasting hormone therapy myths: the idea that the risks are the same for every woman, at every age.

“The women in the study behind two decades of fear averaged 63, well past typical menopause.”

Myth: Hormone Therapy Always Causes Breast Cancer

Not exactly. In long-term WHI follow-up, estrogen plus progestin was linked to more breast cancer diagnoses, while estrogen alone in women who had a hysterectomy was linked to fewer cases and fewer breast cancer deaths. Risk depends on hormone type, duration, personal history, and timing.

Estrogen plus progestin vs. estrogen alone

Progestin is a hormone given with estrogen to protect the uterus lining. Healio reported on WHI long-term data showing about a 29% higher breast cancer incidence with the combination. Estrogen alone, used only by women without a uterus, was tied to about 23% lower incidence and fewer breast cancer deaths.

Your history still matters

None of these findings means hormone therapy is “safe” for everyone. A personal or family history of breast cancer, blood clots, stroke, or liver disease can affect your risk. That is why this decision belongs with your clinician.

It also helps to ask about the type of hormone, the route, and how long you might use it. Those details shape risk far more than the general label “hormone therapy.” A good clinician will walk through your numbers, not someone else’s headline.

What Changed: FDA’s Hormone Therapy Boxed Warning Update

In November 2025, the FDA began removing boxed-warning language about cardiovascular disease, breast cancer, and probable dementia from menopausal hormone therapy labels. In February 2026 it approved the first six revised labels. The endometrial cancer boxed warning still appears on systemic estrogen-alone products, and the label still describes the risks elsewhere.

What was removed and what stayed

A boxed warning (often called a “black box”) is the FDA’s most prominent label caution. According to HHS, the agency asked manufacturers to drop the broad boxed language on heart disease, breast cancer, and dementia. It kept the boxed warning about endometrial cancer, which is cancer of the uterine lining, for systemic estrogen used without a progestogen.

The FDA approved the first revised labels on February 12, 2026, for six products. Twenty-nine companies submitted changes, so updates are rolling out label by label.

The timing window

The updated labels are meant to recommend starting systemic hormone therapy before age 60 or within 10 years of menopause onset. “Systemic” means the hormone travels through the bloodstream, as with pills, patches, or gels.

What this doesn’t mean

The change does not make hormone therapy risk-free. Labels still describe known risks in their other sections, and the update applies only to FDA-approved products. Compounded hormones have no FDA-approved label at all.

Because the rollout happens one product at a time, the label on your specific medication may or may not reflect the new wording yet. Your pharmacist can show you the current label and explain what it says.

Myth: “It’s Too Late for Hormone Therapy After 60”

Age matters, but there is no universal cutoff. The Menopause Society’s 2022 position statement calls hormone therapy the most effective treatment for hot flashes and night sweats. It says benefits generally outweigh risks for healthy women under 60 or within 10 years of menopause.

No automatic stop date

The same statement says hormone therapy does not need to be routinely stopped at 60 or 65. Women with ongoing symptoms can consider continuing after a careful evaluation and counseling.

Starting later is a more individual decision. Your clinician will weigh your heart and clot risks, along with how much your symptoms affect daily life.

Why timing matters

Researchers call this phenomenon the “timing hypothesis.” The idea is that hormone therapy started near menopause behaves differently from therapy started many years later, when blood vessels may have already changed. The WHI follow-up, where women in their 50s fared better, fits that pattern.

Local options for vaginal symptoms

Vaginal dryness and painful intercourse often persist for years after menopause, and they tend to worsen rather than fade with time. Low-dose local therapy acts mainly where it is applied, so many women discuss it with their clinician even when systemic therapy isn’t a fit. Read more about options for vaginal dryness after menopause.

Myth: “Natural” and “Bioidentical” Are Always Safer

This myth runs in the opposite direction. Instead of scaring women away from treatment, it pushes some toward products marketed as gentler or more natural.

Bioidentical is a description, not a safety rating

“Bioidentical” means a hormone has the same molecular structure as the one your body makes. It describes chemistry, not safety. Cleveland Clinic explains that FDA-approved bioidentical estradiol and progesterone products exist, and they have been tested to meet FDA standards.

“Natural” can mislead

Plant-derived hormones, often made from yams or soy, are processed in a lab before they become medication. Your body can’t tell where the molecule started. What matters is the dose, the route, and how well the product is made.

Marketing claims have drawn FDA attention

Claims that compounded versions are safer or more effective remain unsupported. In 2008, the FDA sent warning letters to several pharmacy operations over that kind of marketing. At King’s, we don’t make those claims.

“Bioidentical describes a molecule and its structure, not a safety record or a guarantee.”

Compounded Hormone Therapy: The Honest Facts

Compounded hormones are not FDA-approved. Major groups, including the National Academies (NASEM), ACOG, and the Menopause Society, advise using FDA-approved products when they fit. NASEM said compounded hormones may be appropriate when a patient is allergic to an ingredient in an approved product or needs a dosage form not commercially available.

What NASEM recommended

In its 2020 FDA-sponsored report, the National Academies found insufficient evidence to support the clinical usefulness of compounded bioidentical hormones. It urged prescribers to limit them to specific medical needs and raised concerns about hormone pellets.

The report also recommended that the FDA review several hormones for its “difficult to compound” list. ACOG’s 2023 guidance agrees that compounded hormones shouldn’t be routine when an FDA-approved option works, and it does not recommend hormone level testing to guide dosing.

When compounding makes sense

ACOG gives a practical example: preparing progesterone without peanut oil for a woman with a peanut allergy. Other cases include a strength or form that isn’t commercially available. See our guide to perimenopause symptoms and when compounded hormones may help.

Choosing a quality pharmacy

If your prescriber orders a compounded hormone, choose a pharmacy that is NABP accredited, follows USP standards, and lets you speak with a pharmacist. King’s meets those marks as part of our personalized compounding services.

Getting Help: Questions to Bring to Your Clinician

Hormone therapy myths shouldn’t make your decision for you. Age, timing, hormone type, and your personal history all shape the answer, and the best choice is the one you make with a clinician who knows your history.

Bring these questions to your appointment: Am I within the timing window? Would systemic or local therapy fit my symptoms? Is there an FDA-approved option, or do I need something compounded?

Have questions about whether a compounded hormone is right for you? Talk to your prescribing physician, then connect with the pharmacists at King’s Pharmacy and Compounding Center in Irvine, CA. Contact King’s Pharmacy at 949.387.0780.

Frequently Asked Questions

Did the FDA remove the black box warning on hormone therapy?

Partly. In November 2025 the FDA began removing boxed-warning language about cardiovascular disease, breast cancer, and probable dementia, approving the first six revised labels in February 2026. The endometrial cancer boxed warning remains on systemic estrogen-alone products.

Does hormone therapy cause breast cancer?

It depends on the type. In long-term WHI follow-up, estrogen plus progestin was linked to more breast cancer diagnoses, while estrogen alone after hysterectomy was linked to fewer. Discuss your personal risk with your clinician.

Am I too old to start hormone therapy?

The Menopause Society says benefits generally outweigh risks for healthy women under 60 or within 10 years of menopause onset. Outside that window, the decision is more individual. Your clinician will consider your heart, clot, and cancer risks.

Are bioidentical hormones safer than FDA-approved hormones?

“Bioidentical” describes molecular structure, not safety, and FDA-approved bioidentical estradiol and progesterone products already exist. There is no strong evidence that compounded bioidentical hormones are safer or more effective than FDA-approved options.

When is a compounded hormone appropriate?

The National Academies and ACOG point to specific situations, such as an allergy to an ingredient in an FDA-approved product or a need for a dosage form that isn’t commercially available. Compounded hormones are not FDA-approved and require a prescription.

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Compounded medications require a valid prescription from a licensed prescriber. Always speak with your physician about your specific health needs.

The discomfort rarely arrives as a sudden event. It builds quietly across the day. Focus stays locked at a fixed distance. Blink rate drops. The muscles that adjust for near work stay contracted for hours. By late afternoon the eyes feel dry, tired or simply less sharp than they did in the morning.

Most people respond with temporary fixes. They look away for a few seconds. They adjust the brightness. They hope the next day will feel better. These steps help in the moment. They do little to address the cumulative load that returns every working day.

A consistent approach that includes Eye supplements as one practical layer can change the baseline. The goal is not dramatic improvement overnight. It is steadier comfort across the same number of screen hours.

The nature of the daily load

Digital near-work keeps the eyes in a narrow range of focus for extended periods. Outdoor distance viewing and natural light variation are reduced. The result is a predictable pattern of strain that repeats five or more days a week. Recovery time between sessions is often shorter than the strain period itself.

Temporary relief methods work because they interrupt the pattern briefly. Once the interruption ends, the same conditions resume. Over weeks and months the residual tiredness becomes the new normal.

Matching support to the actual pattern

Screen-heavy days are rarely identical. Some involve long continuous blocks. Others involve frequent switching between devices. The common factor is the total time spent at near distance. Support that is taken every day, regardless of the exact schedule, is more likely to keep pace with that total load.

Forms that are simple to remember and gentle on the system tend to be used longer. Complexity reduces adherence. The practical test is whether the support can survive ordinary busy weeks without being forgotten.

FAQ

Do short breaks during the day still matter if I use daily support?
Yes. Breaks interrupt the continuous near-focus load. Support and breaks address different parts of the same problem.

Is it better to take something only on the heaviest screen days?
Daily consistency usually works better. The strain is cumulative. Intermittent support leaves gaps that match the pattern of the load.

How soon should I expect to notice a difference?
Most people assess comfort over several weeks rather than days. The change is often a quieter baseline rather than a dramatic shift.

Can lifestyle adjustments replace nutritional support?
They reduce the load. Support can still help when the remaining load is high and regular. The two approaches work together.

Users who add Eye supplements as a steady daily element rather than an occasional rescue often report that the late-day tiredness becomes less pronounced. The screen hours themselves do not disappear. The residual cost of those hours becomes easier to carry.

Consistent daily support works better than occasional intense correction. The eyes face the same conditions most days. Matching the support to that regularity gives it the best chance of remaining useful over time.

Many teenagers indulge themselves in various sports activities but some sports like basketball, volleyball or gymnastics involve constant ankle movement and sometimes sudden rolling or twisting of the ankle causes ankle sprain or injury.

This injury interferes with a child’s training, day to day activities and daily comfort. Because this makes even a small movement quite painful. That’s why doctors offer them a pediatric ankle binder that helps with providing constant support to the ankle joint and reducing any sudden rolling or twisting movement that helps them in their training and daily activities.

Moreover it helps them do their training without worrying about any discomfort or injury. The compression can also help with controlling swelling and promotes a faster recovery. Therefore, in this blog we will go through what a pediatric ankle binder is, tips for choosing the right pediatric binder, tips to wear it in a correct way, key benefits and common mistakes one should avoid will help you to get comfort and support during your recovery period.

What is a Pediatric Ankle Binder?

A pediatric ankle binder is a medical device which is specially made for young athletes or teenagers to provide constant support to their ankle joint while restricting the unwanted movement that protects them from any ankle injury or sprain.

The size and design is smaller than an adult binder because the child feets are smaller in design and they feel comfortness while wearing the binder.

Moreover the binder is usually made from materials such as neoprene that provides constant compression to the ankle and prevents injury during training. The breathable and skin friendly also ensures that children do not feel discomfort and is suitable for wearing it for several hours.

Tips for choosing the Right Pediatric Binder

Consider these points when selecting the right pediatric binder:

Right Size Binder

Wearing the right size binder is the first and foremost step. Using an improper binder can cause two possibilities, one if the binder is too tight then it will cause discomfort and numbness on the other hand if it is too loose then it may not provide the appropriate support to the joint and increase the chance of unnecessary movement.

Skin Friendly Binder

Young teenagers will wear the ankle binder for a longer period of time during their training or match. So they should look out for a binder that includes breathable fabric and light weight material that helps in preventing moisture buildup and skin irritation or related issues.

Adequate Compression

Since the young athletes are constantly spending their time on training grounds, they should choose a binder that will provide the appropriate compression and have some adjustable straps to adjust the compression according to our preference. If they experience any kind of numbness or pain then immediately remove the binder and ask advice from someone who knows how to wear it correctly.

Tips to Wear the Binder Correctly

Wearing the ankle in the correct way is important to attain all the benefits and prevent yourself from any discomfort or skin irritation. Follow the given steps to wear the binder properly:

• Ensure that your skin is clean and dry before wearing the ankle binder.
• Place the binder in such a manner that the wider part faces upward
• Now slide your leg into the binder through the wider part just like a sock.
• Adjust the compression such that it feels snugly and you do not face any kind of discomfort.
• If the child experiences any kind of redness, pain or numbness then adjust the compression of the binder to a good compression.

Benefits of Pediatric Binder

An ankle binder provides the following benefits to the teenagers:

Joint Stability

One of the primary purposes of the binder is to provide stability to the ankle joint that helps the teenager to do its training without worrying about the injury. As it reduces the chance of sudden rolling or twisting of the ankle and preventing the injury.

Pain Relief

The binder helps in providing constant support to the ankle joint that reduces the risk of awkward ankle movement which gives relief from the constant ankle pain while doing any activity.

Reduced Swelling

Increased swelling can reduce the blood flow and delays the healing time which will disrupt the training of the child. But an ankle binder helps in providing constant compression that improves blood flow and boosts recovery process and helps the child to join training faster.

Avoid these Common Mistakes

If you avoid these common mistakes while using an ankle binder belt it will provide more comfort and support:

• Wearing the ankle binder for long periods of time without your doctor approval can sometimes cause discomfort and related problems.
• Sharing your binder with other children can lead to skin irritation or infection.
• Wearing a wet or damp binder can cause skin irritation or related problems.
• Ignoring persistent pain or discomfort while wearing can also lead to further damage.

Final Thoughts

Nowadays, young athletes who are into sports that can put sudden pressure on their ankle which can cause injury use an ankle binder. A pediatric ankle binder helps in providing stability to the ankle joint which will help in reducing the twisting or rolling of the ankle and protect the child from an ankle injury.

While athletes who are already recovering from the injury are also using this to get faster and safer recovery. But having some knowledge about what a pediatric ankle binder is, tips to choose the right binder, steps to wear the binder correctly, benefits and mistakes one should avoid to help the child to get a smoother and comfortable experience during their recovery journey.